CARGO Therapeutics, Inc. Common Stock Cash Flow-to-Debt Ratio
CARGO Therapeutics, Inc. Common Stock cash flow-to-debt ratio. CARGO Therapeutics, Inc. Common Stock (CRGX) has a Cash Flow-to-Debt Ratio of -3.70x as of June 2025, meaning its operating cash flow of $-77.38 Million could theoretically repay -4% of its total liabilities ($20.91 Million) in one year. See CRGX free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of CARGO Therapeutics, Inc. Common Stock (2021–2024)
Cash flow-to-debt ratio of CARGO Therapeutics, Inc. Common Stock from 2021 to 2024. Historical debt coverage capacity for CARGO Therapeutics, Inc. Common Stock across 4 annual periods. Also explore CARGO Therapeutics, Inc. Common Stock (CRGX) equity growth momentum to track the company's year-over-year net asset growth rate.
CARGO Therapeutics, Inc. Common Stock Cash Flow-to-Debt Ratio by Year (2021–2024)
CARGO Therapeutics, Inc. Common Stock cash flow-to-debt ratio by year from 2021 to 2024. Year-by-year debt coverage analysis for CARGO Therapeutics, Inc. Common Stock. For the full cash flow conversion analysis, see CRGX operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -2.60x | $-139.74 Million | $53.83 Million | ▼ -52.4% |
| 2023 | -1.70x | $-81.16 Million | $47.65 Million | ▼ -166.5% |
| 2022 | -0.64x | $-29.07 Million | $45.48 Million | ▲ +39.5% |
| 2021 | -1.06x | $-4.94 Million | $4.68 Million | — |